Early Growth Response 1 (Egr-1) Regulates Phosphorylation of Microtubule-associated Protein Tau in Mammalian Brain

被引:43
作者
Lu, Yifan [1 ]
Li, Tong [1 ]
Qureshi, Hamid Y. [1 ]
Han, Dong [1 ]
Paudel, Hemant K. [1 ,2 ]
机构
[1] Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANSCRIPTION FACTOR EGR-1; CYCLIN-DEPENDENT PROTEIN-KINASE-5; NEURONAL CDC2-LIKE KINASE; NF-KAPPA-B; ALZHEIMERS-DISEASE; MOUSE MODEL; GENE-EXPRESSION; TRANSGENIC MICE; IN-VIVO;
D O I
10.1074/jbc.M111.220962
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the normal brain, tau protein is phosphorylated at a number of proline-and non-proline directed sites, which reduce tau microtubule binding and thus regulate microtubule dynamics. In Alzheimer disease (AD), tau is abnormally hyperphosphorylated, leading to neurofibrillary tangle formation and microtubule disruption, suggesting a loss of regulatory mechanisms controlling tau phosphorylation. Early growth response 1 (Egr-1) is a transcription factor that is significantly up-regulated in AD brain. The pathological significance of this up-regulation is not known. In this study, we found that lentivirus-mediated overexpression of Egr-1 in rat brain hippocampus and primary neurons in culture activates proline-directed kinase Cdk5, inactivates PP1, promotes tau phosphorylation at both proline-directed Ser(396/404) and non-proline-directed Ser(262) sites, and destabilizes microtubules. Furthermore, in Egr-1(-/-) mouse brain, Cdk5 activity was decreased, PP1 activity was increased, and tau phosphorylation was reduced at both proline-directed and non-proline-directed sites. By using nerve growth factor-exposed PC12 cells, we determined that Egr-1 activates Cdk5 to promote phosphorylation of tau and inactivates PP1 via phosphorylation. When Cdk5 was inhibited, tau phosphorylation at both proline-and non-proline directed sites and PP1 phosphorylation were blocked, indicating that Egr-1 acts through Cdk5. By using an in vitro kinase assay and HEK-293 cells transfected with tau, PP1, and Cdk5, we found that Cdk5 phosphorylates Ser(396/404) directly. In addition, by phosphorylating and inactivating PP1, Cdk5 promotes tau phosphorylation at Ser(262) indirectly. Our results indicate that Egr-1 is an in vivo regulator of tau phosphorylation and suggest that in AD brain increased levels of Egr-1 aberrantly activate an Egr-1/Cdk5/PP1 pathway, leading to accumulation of hyperphosphorylated tau, thus destabilizing the microtubule cytoskeleton.
引用
收藏
页码:20569 / 20581
页数:13
相关论文
共 76 条
[1]   ROLE OF ABNORMALLY PHOSPHORYLATED TAN IN THE BREAKDOWN OF MICROTUBULES IN ALZHEIMER-DISEASE [J].
ALONSO, AD ;
ZAIDI, T ;
GRUNDKEIQBAL, I ;
IQBAL, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5562-5566
[2]   The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin [J].
Baron, V ;
Adamson, ED ;
Calogero, A ;
Ragona, G ;
Mercola, D .
CANCER GENE THERAPY, 2006, 13 (02) :115-124
[3]  
Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2
[4]   Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease [J].
Begum, Aynun N. ;
Jones, Mychica R. ;
Lim, Giselle P. ;
Morihara, Takashi ;
Kim, Peter ;
Heath, Dennis D. ;
Rock, Cheryl L. ;
Pruitt, Mila A. ;
Yang, Fusheng ;
Hudspeth, Beverly ;
Hu, Shuxin ;
Faull, Kym F. ;
Teter, Bruce ;
Cole, Greg M. ;
Frautschy, Sally A. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 326 (01) :196-208
[5]   Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture [J].
Broussau, Sophie ;
Jabbour, Nadine ;
Lachapelle, Guillaume ;
Durocher, Yves ;
Tom, Rosanne ;
Transfiguracion, Julia ;
Gilbert, Renald ;
Massie, Bernard .
MOLECULAR THERAPY, 2008, 16 (03) :500-507
[6]   Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies [J].
Brunden, Kurt R. ;
Trojanowski, John Q. ;
Lee, Virginia M. -Y. .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (10) :783-793
[7]   Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles [J].
Caccamo, Antonella ;
Oddo, Salvatore ;
Tran, Lana X. ;
LaFerla, Frank M. .
AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (05) :1669-1675
[8]  
Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]
[9]   Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling [J].
Cho, SJ ;
Kang, MJ ;
Homer, RJ ;
Kang, HR ;
Zhang, XC ;
Lee, PJ ;
Elias, JA ;
Lee, CG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (12) :8161-8168
[10]   A decade of CDK5 [J].
Dhavan, R ;
Tsai, LH .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :749-759